Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2025Cancer Immunology ImmunotherapyOpen Access

Precision sniper for solid tumors: CAR-NK cell therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SLSisi LiJJJiajie JingYCYueming Chen

Discussion

Loading...

Member takes

Overview

Review examines CAR-NK cell therapy's efficacy and challenges in solid tumors, highlighting its potential advantages over CAR-T cells.

Key Points

  • CAR-NK cell therapy offers a promising targeted approach for solid tumors, potentially reducing side effects compared to CAR-T therapy.
  • Natural killer (NK) cells can non-specifically lyse various tumor cells, providing a broader attacking strategy in cancer treatment.
  • Challenges like cytokine release syndrome and on-target/off-tumor effects still exist in CAR-NK technology.
  • Research advancements in CAR-NK design and production methods may overcome previous limitations in solid tumor therapies.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/689a0627e6551bb0af8ce0d5https://doi.org/10.1007/s00262-025-04106-z
View Full Paper
Ask AI
Bookmark
Share